North American artificial disc replacement market to reach $614.5 million

The North American artificial disc replacement (ADR) market – which covers Canada, Mexico and the U.S. – is set to more than double from $274.6 million in 2016 to around $614.5 million by 2023, representing a compound annual growth rate of 12.2%, according to research and consulting firm GlobalData. The company’s latest report states that key

Global CT systems market to quadruple by 2023

The market for computed tomography (CT) systems, which are used to generate detailed images of structures inside the body, is set to rise from just under $3.6 billion in 2016 to around $12.1 billion by 2023, representing a compound annual growth rate of 18.2%, according to research and consulting firm GlobalData. The company’s latest report

Medical device companies will need to alter approach to M&A and product offerings in 2017

2017 will be a changeable and productive year for the medical devices industry, as aging populations, the need for cost-effective treatments and consistent innovation continue to drive growth, according to research and consulting firm GlobalData. The company’s latest white paper states that as 2017 approaches, despite the medical devices landscape favoring large companies who can

Operating room equipment market set to hit $1.1 billion by 2023

The global operating room (OR) equipment market, which covers OR tables, OR lights and surgical boom units, is set to rise from just over $920 million in 2016 to around $1.1 billion by 2023, representing a compound annual growth rate of 2.6%, according to research and consulting firm GlobalData. The company’s latest report states that

Improving technology will drive sterilization capital equipment market to $840 million by 2022, says GlobalData

The sterilization capital equipment space across the 10 major markets of the U.S., France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India is set to grow from around $663 million in 2015 to just under $840 million by 2022, according to research and consulting firm GlobalData. The company’s latest report states that this

Global hip and knee reconstruction market expected to hit $16.5 B

The global hip and knee reconstruction market encompasses 39 countries and includes primary, partial, revision hip and knee replacements and hip resurfacing. The market will expand slowly at a compound annual growth rate of 2.5%, from just under $14 billion in 2015 to $16.46 billion by 2022, according to research and consulting firm GlobalData. The

Emerging countries will be fundamental to growth of renal dialysis market

The growth of the global renal dialysis market, which encompasses both the service and equipment segments, was valued at $77 billion in 2015, and is set to expand to $101.9 billion by 2022, will be largely driven by emerging markets such as China, Brazil and India over the next seven years, according to an analyst

Mexico’s medical device market grows due to population increase

Mexico’s medical devices market is set to grow from $4.9 billion in 2015 to $6.5 billion by 2020 as the population increases, adopts more unhealthy lifestyles, and grows older, according to research and consulting firm GlobalData. The company’s latest report states that the resultant prevalence of non-communicable diseases such as cardiovascular disease, respiratory disease, metabolic

Global renal dialysis equipment market rises

The global renal dialysis equipment market will rise steadily from $14.44 billion in 2015 to over $18 billion by 2022, representing a Compound Annual Growth Rate (CAGR) of 3.48%, according to research and consulting firm GlobalData. The company’s latest report states that this growth, which will occur across the 10 major markets of the U.S.

Fine Needle Aspiration market to stagnate as doctors shift to Core Needle Biopsy

The Fine Needle Aspiration (FNA) segment of the biopsy market is set to remain relatively stagnant over the next few years, rising only slightly from $56 million in 2015 to $59.2 million in 2022, at a Compound Annual Growth Rate (CAGR) of 0.81%, according to research and consulting firm GlobalData. The company’s report states that

Peripheral vascular interventions market will climb to $3.4 billion by 2022, says GlobalData

The global market for peripheral vascular interventions, including lower extremity stents, percutaneous transluminal angioplasty (PTA) balloons, PTA drug-eluting balloons (DEB), carotid stents, and renal stents, will rise from $2.1 billion in 2015 to $3.4 billion by 2022, says research and consulting firm GlobalData. According to the company’s latest report*, this expansion, which will occur at

Stenting will continue to be a viable alternative to surgery in carotid artery stenosis, says GlobalData Analyst

Recent results from a trial known as the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST), showing that patients with severe carotid artery stenosis suffered similar rates of adverse events in both stenting and endarterectomy procedures, are evidence that stenting will continue to remain competitive with surgical treatment, says an analyst with research and consulting firm